SCIENTIFIC PROGRAM

13th National Haemostasis Update (NHU 2024)
(The timings mentioned are as per the Indian Standard Time - IST)
07:30 - 08:50 Registration
Hall A
08:50 - 09:00 Welcome Note
Time (IST) Topic
09:00 - 09:40 Plenary 1
Co-Chairs:
Liane Khoo,
Royal Prince Alfred Hospital,Sydney
Chandrakala S,
King Edward Memorial Hospital, Mumbai
09:00 - 09:30 Redefining Goals of Haemophilia Therapy in the Era of Non-Factor Replacement
Speaker:
Guy Young,
Children’s Hospital, Los Angeles (Virtual)
09:30 - 09:40 Discussion
Hall A Hall B
Time (IST) Topic Topic
09:45 - 11:00 Scientific Session 1A
Theme: Von Willebrand Disease
Co-Chairs:
Bunchoo Pongtanakul,
Siriraj Hospital, Bangkok
Naresh Gupta,
Maulana Azad Medical College, New Delhi		 Scientific Session 1B
Theme: MSK
Chair:
Nittu Panjikaran,
Amrita Institute of Medical Science, Kochi.
09:45 - 10:10 Challenges in von Willebrand Disease Diagnosis in Low- and Middle-Income Countries: The Way Forward.
Speaker:
Jasmina Ahluwalia,
PGIMER Chandigarh, Chandigarh.		 Radioactive Synovectomy
Speaker:
Naveen Cherian Thomas,
Christian Medical College, Vellore.
10:10 - 10:35 Shifting Paradigms: Genomic Diagnosis as an Effective Substitute For Functional Testing in Von Willebrand Disease for Low Middle Income Countries
Speaker:
Michelle Lavin,
National Coagulation Centre, St. James's Hospital, Dublin.		 Panel Discussion -
Ankle Treatment Options

Moderator:
Naveen Cherian Thomas,
Christian Medical College, Vellore.

Panelist:
a) Rohini Dange,
Sahyadri Hospital, Pune.
b) Shigy Francis,
Lisie Hospital, Ernakulum.
c) Mohd. Helmi Bin Hashim,
Hospital Sultanah Bahiyah, Alor Setar.
10:35 - 11:00 Improving von Willebrand Disease Outcomes in Low- and Middle-Income Countries
Speaker:
Jameela Sathar,
Hospital Ampang, Ampang.		 Osteoporosis in PwH
Speaker:
Kumiko Ono,
The University of Tokyo, Tokyo
(Virtual)
11:00 - 11:30 Tea Break with Poster Viewing
11:35 - 12:35 Sponsored Symposium I:
Novo Nordisk (Room 1)
 One Factor Many Possibilities
Chairperson : Naresh Gupta		 Sponsored Symposium II:
Takeda (Room 2)
 Revisiting Management of Patients with CHAWI – From Expert Opinion to Clinical Decision
11:35 - 11:40 Managing breakthrough bleeds in inhibitor patients
Speaker:
Kapil Garg		 11:35 - 11:37 Welcome Note
Takeda Medical Affairs Team
11:35 - 11:45 The Multiple Indications of Extended Half Life Factors 11:37 - 11:40 Context setting and Introduction to speaker
Speaker:
Alok Srivastava,
Christian Medical College Vellore
11:45 - 12:10 Panel Discussion: EHLs in Prophylaxis Use of EHLs in Prophylaxis – Insights from Experience
Speakers:
Nita Radhakrishnan, Kapil Garg, Nehal Patel, Bilal Ahmad Sheikh, S P Verma, Sunita Aggarwal		 11:40 - 12:00 Co-treatment of BPA with non-factor therapy in CHAWI patients
Speaker:
Guy Young,
Children’s Hospital Los Angeles
12:00 - 12:10 Q & A

Moderator:
Alok Srivastava,
Christian Medical College Vellore

Panelist:
Guy young,
Children’s Hospital Los Angeles
Tulika Seth,
AIIMS, New Delhi
Chandrakala S,
King Edward Memorial Hospital, Mumbai
Neeraj Sidharthan,
AIMS, Cochin
12:10 - 12:35 Panel Discussion - EHLs in Surgery and other Scenarios Perioperative management with EHLs: Experience from Major Surgeries
Speakers:
Vishnu Sharma Meera, Sudhir Atri, Varun Bafna, Sachin Bansal, Varun Kaul
12:10 - 12:20 Role of APCC in CHAWI patients undergoing surgery
Speaker:
Chandrakala S,
King Edward Memorial Hospital, Mumbai
12:20 - 12:32 Q & A

Moderator:
Chandrakala S

Panelist:
Alok Srivastava, Guy young, Tulika Seth, Neeraj Sidharthan
12:32 - 12:35 Concluding Remarks
Speaker:
Alok Srivastava
12:35 - 13:30 Lunch
13:35 - 14:30 Scientific Session 2A
Theme: Bridging Trends in Haemophilia
Co-Chairs:
Jiaan Der Wang,
Taichung Veterans General Hospital, Taichung
Neeraj Sidharthan,
Amrita Institute of Medical Sciences, Kochi		 13:35 - 14:30 Scientific Session 2B
(Nursing)
Chair:
Divya Varghese,
St John’s Medical College Hospital, Bengaluru
Time (IST) Topic Time (IST) Topic
13:35 - 14:00 Emerging Trends in The Management Acquired Haemophilia A
Speaker:
Nguyen Thi Mai,
National Institute of Hematology and Blood Transfusion, Hanoi		 13:35 - 13:40 Introduction
14:00 - 14:30 Panel Discussion -
Newly Diagnosed Haemophilia: Insights from Different Countries

Moderator:
Rattapan Lamool,
Pramongkut Hospital, Bangkok.

Panelists:
Sing Heng,
Angkor Hospital for Children, Siem Reap.
Sein Win,
Yangon General Hospital, Yangon.
Thamudika Vithanage,
National Hospital of Sri Lanka, Colombo.
Akhil Ranjon Biswas,
Dhaka Medical College, Dhaka.
Bishesh Sharma Poudyal,
Civil Service Hospital, Kathmandu.		 13:40 - 13:55 Haemophilia Nurse in Asia-Pacific:
The insider Stories
Speaker:
Lim Chiew Ying,
KK Women’s and Children’s Hospital, Singapore
13:55 - 14:10 Professional Framework for Becoming a Specialist Haemophilia Nurse
Speaker:
Alex Klever,
Royal Brisbane and Women’s Hospital, Queensland (Virtual)
14:10 - 14:25 Snapshots of 3 Haemophilia Treatment Centres in Asia Pacific
Speakers:
a) Radhika Basi,
Civil Service Hospital, Kathmandu
b) Dita Rizkiya Yusnita,
Dr Cipto Mangunkusumo Hospital, Jakarta
c) Aoi Nakazawa,
Ogikubo Hospital, Tokyo (Virtual)
14:25 - 14:30 Discussion
Hall A
14:35 - 15:15 Plenary 2
Co-Chairs:
Jameela Sathar,
Hospital Ampang, Ampang
Meera V,
Bangalore Medical College and Research Institute, Bangalore
14:35 - 15:05 Health Economic and Haemophilia Care: Value, Innovation, and Access.
Speaker:
Louis Garrison,
University of Washington, Washington (Virtual)
15:05 - 15:15 Discussion
15:20 - 16:20 Sponsored Symposium III:
Roche (Room 1)
Chair: Naresh Gupta		 Sponsored Symposium IV:
Octapharma (Room 2)
Time (IST) Topic Time (IST) Topic
15:20 - 15:30 Single centre Experience of Emicizumab
Speaker:
Lorraine D'sa,
GMC, Goa		 15:20 - 15:27 Welcome and Introduction
Speaker:
Craig Kessler,
US
15:30 - 15:40 Experience with Emicizumab in Karnataka
Speaker:
Cecil Ross,
St. Johns, Banglore		 15:27 - 15:42 The Enduring Relevance of FVIII in Haemophilia A Management
Speaker:
Anthony Chan,
Canada
15:40 - 15:50 Single centre Experience of Emicizumab: J&K
Speaker:
Bilal Ahmed Sheikh,
SMHS, Srinagar		 15:42 - 15:57 Making Informed Treatment Decisions for Prophylaxis in Haemophilia A
Speaker:
Craig Kessler,
US
15:50 - 16:20 Optimal care in Hemophilia: Role of Emicizumab

Moderator:
Anupam Dutta,
AMCH, Guwahati

Panelists:
Rahul R,
NHM, Kerala
Vishnu Sharma,
SMS, Jaipur
Chandrakala S,
KEM, Mumbai
S P Verma,
KGMU, Lucknow
K K Radhika,
NIMS, Hyderabad
Varun Kaul,
GGMCH, Faridkot
Tulika Seth,
AIIMS, New Delhi		 15:57 - 16:02 Navigating the Unique Challenges in VWD
Speaker:
Predrag Miljic,
Serbia
16:02 - 16:20 Q & A
Speaker:
All Faculty
16:20 - 16:50 Tea Break with Poster Viewing
Hall A Hall B
Time (IST) Topic Topic
16:55 - 18:10 Scientific Session 3A
Theme: Difficult Bleeds in Haemophilia Care: Challenges and Solutions
Co-Chairs:
Chean Sophal,
National Pediatric Hospital, Phnom Penh
Aby Abraham,
Christian Medical College, Vellore		 Scientific Session 3B
Theme: Advances in Diagnosing Bleeding Disorders
Co-Chairs:
Tien Sim Leng,
Singapore General Hospital, Singapore
Jasmina Ahluwalia,
PGIMER Chandigarh, Chandigarh
16:55 - 17:20 Recurrent Pseudotumours in Haemophilia: Evidence Based management
Speaker:
Tulika Seth,
All India Institute of Medical Sciences, New Delhi.		 The Institutional Approach for Diagnosis and Management of Children with Bleeding of Unknown Cause
Speaker:
Nongnuch Sirachainan,
Ramathibodi Hospital, Bangkok.
17:20 - 17:45 Optimal Treatment Strategies in Prevention of Intracranial Bleeding in Haemophilia Patients
Speaker:
Meera B Chitlur,
Children’s Hospital of Michigan, Detroit.		 New Developments in Inhibitor Detection and Quantification
Speaker:
Bert Verbruggen,
Radboud University Nijmegen Medical Centre, The Netherlands.
17:45 - 18:10 Managing Major Bleeds in Inhibitor-Positive Haemophilia: Challenges and Innovations
Speaker:
Darintr Sosothikul,
Chulalongkorn University, Bangkok.		 How to Make Diagnosis of Bleeding Disorders Accessible and Cost Effective?
Speaker:
Nitty S Mathews,
Christian Medical College, Vellore
19:30 Onwards Dinner

SCIENTIFIC PROGRAM

13th National Haemostasis Update (NHU 2024)
(The timings mentioned are as per the Indian Standard Time - IST)
07:30 - 08:50 Registration
Hall A
08:50 - 09:00 Welcome Note
Time (IST) Topic
09:00 - 09:40 Plenary 1
Co-Chairs:
Liane Khoo,
Royal Prince Alfred Hospital,Sydney
Chandrakala S,
King Edward Memorial Hospital, Mumbai
09:00 - 09:30 Redefining Goals of Haemophilia Therapy in the Era of Non-Factor Replacement
Speaker:
Guy Young,
Children’s Hospital, Los Angeles (Virtual)
09:30 - 09:40 Discussion
Hall A Hall B
Time (IST) Topic Topic
09:45 - 11:00 Scientific Session 1A
Theme: Von Willebrand Disease
Co-Chairs:
Bunchoo Pongtanakul,
Siriraj Hospital, Bangkok
Naresh Gupta,
Maulana Azad Medical College, New Delhi		 Scientific Session 1B
Theme: MSK
Chair:
Nittu Panjikaran,
Amrita Institute of Medical Science, Kochi.
09:45 - 10:10 Challenges in von Willebrand Disease Diagnosis in Low- and Middle-Income Countries: The Way Forward.
Speaker:
Jasmina Ahluwalia,
PGIMER Chandigarh, Chandigarh.		 Radioactive Synovectomy
Speaker:
Naveen Cherian Thomas,
Christian Medical College, Vellore.
10:10 - 10:35 Shifting Paradigms: Genomic Diagnosis as an Effective Substitute For Functional Testing in Von Willebrand Disease for Low Middle Income Countries
Speaker:
Michelle Lavin,
National Coagulation Centre, St. James's Hospital, Dublin.		 Panel Discussion -
Ankle Treatment Options

Moderator:
Naveen Cherian Thomas,
Christian Medical College, Vellore.

Panelist:
a) Rohini Dange,
Sahyadri Hospital, Pune.
b) Shigy Francis,
Lisie Hospital, Ernakulum.
c) Mohd. Helmi Bin Hashim,
Hospital Sultanah Bahiyah, Alor Setar.
10:35 - 11:00 Improving von Willebrand Disease Outcomes in Low- and Middle-Income Countries
Speaker:
Jameela Sathar,
Hospital Ampang, Ampang.		 Osteoporosis in PwH
Speaker:
Kumiko Ono,
The University of Tokyo, Tokyo
(Virtual)
11:00 - 11:30 Tea Break with Poster Viewing
11:35 - 12:35 Sponsored Symposium I:
Novo Nordisk (Room 1)
 One Factor Many Possibilities
Chairperson : Naresh Gupta		 Sponsored Symposium II:
Takeda (Room 2)
 Revisiting Management of Patients with CHAWI – From Expert Opinion to Clinical Decision
11:35 - 11:40 Managing breakthrough bleeds in inhibitor patients
Speaker:
Kapil Garg		 11:35 - 11:37 Welcome Note
Takeda Medical Affairs Team
11:35 - 11:45 The Multiple Indications of Extended Half Life Factors 11:37 - 11:40 Context setting and Introduction to speaker
Speaker:
Alok Srivastava,
Christian Medical College Vellore
11:45 - 12:10 Panel Discussion: EHLs in Prophylaxis Use of EHLs in Prophylaxis – Insights from Experience
Speakers:
Nita Radhakrishnan, Kapil Garg, Nehal Patel, Bilal Ahmad Sheikh, S P Verma, Sunita Aggarwal		 11:40 - 12:00 Co-treatment of BPA with non-factor therapy in CHAWI patients
Speaker:
Guy Young,
Children’s Hospital Los Angeles
12:00 - 12:10 Q & A

Moderator:
Alok Srivastava,
Christian Medical College Vellore

Panelist:
Guy young,
Children’s Hospital Los Angeles
Tulika Seth,
AIIMS, New Delhi
Chandrakala S,
King Edward Memorial Hospital, Mumbai
Neeraj Sidharthan,
AIMS, Cochin
12:10 - 12:35 Panel Discussion - EHLs in Surgery and other Scenarios Perioperative management with EHLs: Experience from Major Surgeries
Speakers:
Vishnu Sharma Meera, Sudhir Atri, Varun Bafna, Sachin Bansal, Varun Kaul
12:10 - 12:20 Role of APCC in CHAWI patients undergoing surgery
Speaker:
Chandrakala S,
King Edward Memorial Hospital, Mumbai
12:20 - 12:32 Q & A

Moderator:
Chandrakala S

Panelist:
Alok Srivastava, Guy young, Tulika Seth, Neeraj Sidharthan
12:32 - 12:35 Concluding Remarks
Speaker:
Alok Srivastava
12:35 - 13:30 Lunch
13:35 - 14:30 Scientific Session 2A
Theme: Bridging Trends in Haemophilia
Co-Chairs:
Jiaan Der Wang,
Taichung Veterans General Hospital, Taichung
Neeraj Sidharthan,
Amrita Institute of Medical Sciences, Kochi		 13:35 - 14:30 Scientific Session 2B
(Nursing)
Chair:
Divya Varghese,
St John’s Medical College Hospital, Bengaluru
Time (IST) Topic Time (IST) Topic
13:35 - 14:00 Emerging Trends in The Management Acquired Haemophilia A
Speaker:
Nguyen Thi Mai,
National Institute of Hematology and Blood Transfusion, Hanoi		 13:35 - 13:40 Introduction
14:00 - 14:30 Panel Discussion -
Newly Diagnosed Haemophilia: Insights from Different Countries

Moderator:
Rattapan Lamool,
Pramongkut Hospital, Bangkok.

Panelists:
Sing Heng,
Angkor Hospital for Children, Siem Reap.
Sein Win,
Yangon General Hospital, Yangon.
Thamudika Vithanage,
National Hospital of Sri Lanka, Colombo.
Akhil Ranjon Biswas,
Dhaka Medical College, Dhaka.
Bishesh Sharma Poudyal,
Civil Service Hospital, Kathmandu.		 13:40 - 13:55 Haemophilia Nurse in Asia-Pacific:
The insider Stories
Speaker:
Lim Chiew Ying,
KK Women’s and Children’s Hospital, Singapore
13:55 - 14:10 Professional Framework for Becoming a Specialist Haemophilia Nurse
Speaker:
Alex Klever,
Royal Brisbane and Women’s Hospital, Queensland (Virtual)
14:10 - 14:25 Snapshots of 3 Haemophilia Treatment Centres in Asia Pacific
Speakers:
a) Radhika Basi,
Civil Service Hospital, Kathmandu
b) Dita Rizkiya Yusnita,
Dr Cipto Mangunkusumo Hospital, Jakarta
c) Aoi Nakazawa,
Ogikubo Hospital, Tokyo (Virtual)
14:25 - 14:30 Discussion
Hall A
14:35 - 15:15 Plenary 2
Co-Chairs:
Jameela Sathar,
Hospital Ampang, Ampang
Meera V,
Bangalore Medical College and Research Institute, Bangalore
14:35 - 15:05 Health Economic and Haemophilia Care: Value, Innovation, and Access.
Speaker:
Louis Garrison,
University of Washington, Washington (Virtual)
15:05 - 15:15 Discussion
15:20 - 16:20 Sponsored Symposium III:
Roche (Room 1)
Chair: Naresh Gupta		 Sponsored Symposium IV:
Octapharma (Room 2)
Time (IST) Topic Time (IST) Topic
15:20 - 15:30 Single centre Experience of Emicizumab
Speaker:
Lorraine D'sa,
GMC, Goa		 15:20 - 15:27 Welcome and Introduction
Speaker:
Craig Kessler,
US
15:30 - 15:40 Experience with Emicizumab in Karnataka
Speaker:
Cecil Ross,
St. Johns, Banglore		 15:27 - 15:42 The Enduring Relevance of FVIII in Haemophilia A Management
Speaker:
Anthony Chan,
Canada
15:40 - 15:50 Single centre Experience of Emicizumab: J&K
Speaker:
Bilal Ahmed Sheikh,
SMHS, Srinagar		 15:42 - 15:57 Making Informed Treatment Decisions for Prophylaxis in Haemophilia A
Speaker:
Craig Kessler,
US
15:50 - 16:20 Optimal care in Hemophilia: Role of Emicizumab

Moderator:
Anupam Dutta,
AMCH, Guwahati

Panelists:
Rahul R,
NHM, Kerala
Vishnu Sharma,
SMS, Jaipur
Chandrakala S,
KEM, Mumbai
S P Verma,
KGMU, Lucknow
K K Radhika,
NIMS, Hyderabad
Varun Kaul,
GGMCH, Faridkot
Tulika Seth,
AIIMS, New Delhi		 15:57 - 16:02 Navigating the Unique Challenges in VWD
Speaker:
Predrag Miljic,
Serbia
16:02 - 16:20 Q & A
Speaker:
All Faculty
16:20 - 16:50 Tea Break with Poster Viewing
Hall A Hall B
Time (IST) Topic Topic
16:55 - 18:10 Scientific Session 3A
Theme: Difficult Bleeds in Haemophilia Care: Challenges and Solutions
Co-Chairs:
Chean Sophal,
National Pediatric Hospital, Phnom Penh
Aby Abraham,
Christian Medical College, Vellore		 Scientific Session 3B
Theme: Advances in Diagnosing Bleeding Disorders
Co-Chairs:
Tien Sim Leng,
Singapore General Hospital, Singapore
Jasmina Ahluwalia,
PGIMER Chandigarh, Chandigarh
16:55 - 17:20 Recurrent Pseudotumours in Haemophilia: Evidence Based management
Speaker:
Tulika Seth,
All India Institute of Medical Sciences, New Delhi.		 The Institutional Approach for Diagnosis and Management of Children with Bleeding of Unknown Cause
Speaker:
Nongnuch Sirachainan,
Ramathibodi Hospital, Bangkok.
17:20 - 17:45 Optimal Treatment Strategies in Prevention of Intracranial Bleeding in Haemophilia Patients
Speaker:
Meera B Chitlur,
Children’s Hospital of Michigan, Detroit.		 New Developments in Inhibitor Detection and Quantification
Speaker:
Bert Verbruggen,
Radboud University Nijmegen Medical Centre, The Netherlands.
17:45 - 18:10 Managing Major Bleeds in Inhibitor-Positive Haemophilia: Challenges and Innovations
Speaker:
Darintr Sosothikul,
Chulalongkorn University, Bangkok.		 How to Make Diagnosis of Bleeding Disorders Accessible and Cost Effective?
Speaker:
Nitty S Mathews,
Christian Medical College, Vellore
19:30 Onwards Dinner

 


Quick Links

Reach Us

  • Association for Haemophilia and Allied Disorders-Asia Pacific